Histone profiling reveals the H1.3 histone variant as a prognostic biomarker for pancreatic ductal adenocarcinoma

Histone profiling reveals the H1.3 histone variant as a prognostic biomarker for pancreatic ductal adenocarcinoma

Abstract Background Epigenetic alterations have been recognized as important contributors to the pathogenesis of PDAC. However, the role of histone variants in pancreatic tumor progression is still not completely understood. The aim of this study was to explore the expression and prognostic signific...

Full description

Bibliographic Details
Main Authors: Monika Bauden, Theresa Kristl, Agata Sasor, Bodil Andersson, György Marko-Varga, Roland Andersson, Daniel Ansari
Format: Article
Language:English
Published: BMC 2017-12-01
Series:BMC Cancer
Subjects:
Biomarkers
Epigenetics
Histone variants
H1.3
LC-MS/MS
Immunohistochemistry
Online Access:http://link.springer.com/article/10.1186/s12885-017-3834-z

Internet

http://link.springer.com/article/10.1186/s12885-017-3834-z

Similar Items